Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
The present invention relates to the use of prolonged release combinations of hydromorphone hydrochloride and naloxone hydrochloride in a weight ratio corresponding to about 1:2 of hydromorphone HCl:naloxone HCl for the preparation of a medicament for the treatment of pain in a patient, wherein the...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to the use of prolonged release combinations of hydromorphone hydrochloride and naloxone hydrochloride in a weight ratio corresponding to about 1:2 of hydromorphone HCl:naloxone HCl for the preparation of a medicament for the treatment of pain in a patient, wherein the medicament is formulated for oral administration of hydromorphone hydrochloride in a daily amount corresponding to from and including about 24 mg up to and including about 48 mg of hydromorphone hydrochloride, and naloxone hydrochloride in a daily amount corresponding to from and including about 48 mg up to and including about 96 mg of naloxone hydrochloride. |
---|